Parametric model of combination therapy for Non-Hodgkin Lymphoma.
The development and clinical testing of drug combinations for the treatment of Non-Hodgkin Lymphoma (NHL) and other cancers has recently shown great promise. However, determining the optimum combination and its associated dosages for maximum efficacy and minimum side effects is still a challenge. Th...
Main Authors: | Robert F Weiss, Merlin G Miller, John F Cronin, Harvey H Hensley, Indira D Joshi, Mitchell R Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3522695?pdf=render |
Similar Items
-
New approaches for combined therapy of Hodgkin's lymphoma
by: P. V. Dacenko, et al.
Published: (2022-11-01) -
Optimization on the combination of treatment for non-hodgkin lymphoma
by: Ahmad, Rohanin, et al.
Published: (2018) -
Understanding metabolic parametrs in Hodgkin lymphoma- Do they predict response to chemotherapy?
by: Piali mandal, et al.
Published: (2022-01-01) -
Non-Hodgkin's lymphoma after immunosuppressive therapy.
by: Kinlen, L
Published: (2000) -
Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01)